학술논문
Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- Metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice
Document Type
Article
Author
Kolyadina, I.V.; Ganshina, I.P.; Abidova, N.R.; Akopyan, A.A.; Volkonskiy, M.V.; Luev, I.A.; Stroyakovskiy, D.L.; Antonova, G.V.; Arapova, O.I.; Kuchevskaya, O.A.; Maistrenko, K.S.; Markizova, E.V.; Shangina, I.A.; Bobrova, E.A.; Egurenkova, V.S.; Zhukova, L.G.; Kuzmicheva, S.V.; Marfutov, V.V.; Merzlikina, Y.I.; Bolotina, L.V.; Valiakhmetova, C.Kh.; Sultanbaev, A.V.; Vasilevskaya, A.V.; Yakubova, M.Zh.; Vladimirova, L.Yu.; Samaneva, N.Yu.; Storozhakova, A.E.; Gudkova, I.E.; Dergunov, A.S.; Evstigneeva, I.V.; Emshanov, A.V.; Zueva, E.V.; Nersesova, T.A.; Stativko, O.A.; Fedorova, A.N.; Karabina, E.V.; Kolokolov, J.J.; Medvedev, S.P.; Ovchinnikova, E.G.; Orlova, S.A.; Tekeeva, A.I.; Fadeeva, N.V.; Shalaeva, O.M.; Shirokova, O.N.; Shumskikh, A.R.
Source
In: Journal of Modern Oncology . (Journal of Modern Oncology, 2021, 23(1):68-76)
Subject
Language
English
Russian
Russian
ISSN
18151442
18151434
18151434